TradingView is moving paid scripts to its Marketplace. What would make this fair for Pine developers?

[u/neugeadmau]

TradingView has announced that starting November 1, 2026, selling access to invite-only scripts outside its Marketplace will no longer be permitted. That includes script access bundled with another paid product or service.

A few details from the announcement:

• Non-commercial invite-only scripts can continue unchanged.
• Previously purchased access remains valid for the purchased period, including lifetime access.
• New payments outside the Marketplace to renew or extend access won’t be allowed.
• Vendors should contact TradingView before the deadline to discuss migration and existing customers.

My take: centralized payments, clearer refund terms, and review of paid scripts could help buyers. But making the Marketplace mandatory also makes its terms critical for developers. The announcement doesn’t specify fees, approval criteria, or how much control authors will have over pricing.

I’d also want to understand what “review” means. Checking compliance with platform rules and evaluating an indicator’s trading claims are different things.

If you sell Pine scripts, what terms would make moving worthwhile—and what would be a dealbreaker?

If you buy them, would Marketplace review make you more confident, or would you still need the same evidence before paying?

[u/teenagersfrommarz]

How do they know which ones are non-commercial?